Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Prognostic nutritional index and early mortality with percutaneous endoscopic gastrostomy.

Adachi Y, Akino K, Nojima M, Himori R, Kikuchi T, Mita H, Nakamura M, Tsukuda H, Yamano HO, Sasaki Y, Yoshida Y, Kato Y, Nakase H, Endo T.

QJM. 2018 Jun 23. doi: 10.1093/qjmed/hcy137. [Epub ahead of print]

PMID:
29939360
2.

Oncocytic Type Intraductal Papillary Mucinous Neoplasm of the Pancreas with Unusually Low Mucin Production Mimicking Intraductal Tubulopapillary Neoplasm: A Report of a Case Diagnosed by a Preoperative Endoscopic Biopsy.

Yoshida Y, Endo T, Tanaka E, Kikuchi T, Akino K, Mita H, Adachi Y, Nakamura M, Adachi Y, Ishii Y, Matsumoto J, Hirano S, Nitta T, Mitsuhashi T, Kato Y.

Intern Med. 2017 Dec 1;56(23):3183-3188. doi: 10.2169/internalmedicine.9053-17. Epub 2017 Oct 11.

3.

Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan.

Tsuda M, Asaka M, Kato M, Matsushima R, Fujimori K, Akino K, Kikuchi S, Lin Y, Sakamoto N.

Helicobacter. 2017 Oct;22(5). doi: 10.1111/hel.12415. Epub 2017 Aug 3.

4.

Systemic Prophylactic Antibiotics for the Modified Introducer Method for Percutaneous Endoscopic Gastrostomy: A Prospective, Randomized, Double-Blind Study.

Adachi Y, Akino K, Mita H, Kikuchi T, Yamashita K, Sasaki Y, Arimura Y, Endo T.

J Clin Gastroenterol. 2016 Oct;50(9):727-32. doi: 10.1097/MCG.0000000000000470.

PMID:
26756107
5.

Anaplastic Carcinoma Possibly Arising from a Heterotopic Pancreas.

Adachi Y, Mita H, Takahashi H, Akino K, Kikuchi T, Ishii Y, Endo T.

Intern Med. 2015;54(23):3017-22. doi: 10.2169/internalmedicine.54.5043. Epub 2015 Dec 1.

6.

Basic Fibroblast Growth Factor in Scarless Wound Healing.

Akita S, Akino K, Hirano A.

Adv Wound Care (New Rochelle). 2013 Mar;2(2):44-49. Review.

7.

Computed tomography just after endoscopy as the preoperative examination for safe percutaneous endoscopic gastrostomy.

Adachi Y, Akino K, Mita H, Kikuchi T, Endo T.

Digestion. 2013;88(2):125-7. doi: 10.1159/000353449. Epub 2013 Aug 20. No abstract available.

8.

Hepatic portal venous gas in pancreatic solitary metastasis from an esophageal squamous cell carcinoma.

Sawada T, Adachi Y, Noda M, Akino K, Kikuchi T, Mita H, Ishii Y, Endo T.

Hepatobiliary Pancreat Dis Int. 2013 Feb;12(1):103-5.

PMID:
23392807
9.

Endoscopic features of primary amyloidosis of the stomach.

Sawada T, Adachi Y, Akino K, Arimura Y, Ishida T, Ishii Y, Endo T.

Endoscopy. 2012;44 Suppl 2 UCTN:E275-6. doi: 10.1055/s-0032-1309750. Epub 2012 Jul 13. No abstract available.

PMID:
22814919
10.

Early experiences with stem cells in treating chronic wounds.

Akita S, Yoshimoto H, Akino K, Ohtsuru A, Hayashida K, Hirano A, Suzuki K, Yamashita S.

Clin Plast Surg. 2012 Jul;39(3):281-92. doi: 10.1016/j.cps.2012.04.005. Epub 2012 May 22. Review.

PMID:
22732376
11.

Noncultured autologous adipose-derived stem cells therapy for chronic radiation injury.

Akita S, Akino K, Hirano A, Ohtsuru A, Yamashita S.

Stem Cells Int. 2010 Dec 1;2010:532704. doi: 10.4061/2010/532704.

12.

Basic fibroblast growth factor is beneficial for postoperative color uniformity in split-thickness skin grafting.

Akita S, Akino K, Yakabe A, Tanaka K, Anraku K, Yano H, Hirano A.

Wound Repair Regen. 2010 Nov-Dec;18(6):560-6. doi: 10.1111/j.1524-475X.2010.00620.x. Epub 2010 Sep 24.

PMID:
20868384
13.

Mesenchymal stem cell therapy for cutaneous radiation syndrome.

Akita S, Akino K, Hirano A, Ohtsuru A, Yamashita S.

Health Phys. 2010 Jun;98(6):858-62. doi: 10.1097/HP.0b013e3181d3d52c.

PMID:
20445394
14.

Relationship between folic acid intake and gingival health in non-smoking adults in Japan.

Esaki M, Morita M, Akhter R, Akino K, Honda O.

Oral Dis. 2010 Jan;16(1):96-101. doi: 10.1111/j.1601-0825.2009.01619.x. Epub 2009 Aug 28.

PMID:
19732352
15.

Basic fibroblast growth factor accelerates and improves second-degree burn wound healing.

Akita S, Akino K, Imaizumi T, Hirano A.

Wound Repair Regen. 2008 Sep-Oct;16(5):635-41. doi: 10.1111/j.1524-475X.2008.00414.x.

PMID:
19128258
16.

Human mesenchymal stem cells may be involved in keloid pathogenesis.

Akino K, Akita S, Yakabe A, Mineda T, Hayashi T, Hirano A.

Int J Dermatol. 2008 Nov;47(11):1112-7. doi: 10.1111/j.1365-4632.2008.03380.x.

PMID:
18986439
17.

A basic fibroblast growth factor improves lower extremity wound healing with a porcine-derived skin substitute.

Akita S, Akino K, Tanaka K, Anraku K, Hirano A.

J Trauma. 2008 Mar;64(3):809-15. doi: 10.1097/TA.0b013e31802c8247.

PMID:
18332828
18.

Cytoplasmic RASSF2A is a proapoptotic mediator whose expression is epigenetically silenced in gastric cancer.

Maruyama R, Akino K, Toyota M, Suzuki H, Imai T, Ohe-Toyota M, Yamamoto E, Nojima M, Fujikane T, Sasaki Y, Yamashita T, Watanabe Y, Hiratsuka H, Hirata K, Itoh F, Imai K, Shinomura Y, Tokino T.

Carcinogenesis. 2008 Jul;29(7):1312-8. doi: 10.1093/carcin/bgn060. Epub 2008 Feb 29.

19.

Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma.

Imai T, Toyota M, Suzuki H, Akino K, Ogi K, Sogabe Y, Kashima L, Maruyama R, Nojima M, Mita H, Sasaki Y, Itoh F, Imai K, Shinomura Y, Hiratsuka H, Tokino T.

Cancer Sci. 2008 May;99(5):958-66. doi: 10.1111/j.1349-7006.2008.00769.x. Epub 2008 Feb 24.

20.

Combined surgical excision and radiation therapy for keloid treatment.

Akita S, Akino K, Yakabe A, Imaizumi T, Tanaka K, Anraku K, Yano H, Hirano A.

J Craniofac Surg. 2007 Sep;18(5):1164-9.

PMID:
17912105
21.

Acceleration of sensory neural regeneration and wound healing with human mesenchymal stem cells in immunodeficient rats.

Imaizumi T, Akita S, Akino K, Hirano A.

Stem Cells. 2007 Nov;25(11):2956-63. Epub 2007 Aug 16.

22.

Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer.

Akino K, Toyota M, Suzuki H, Imai T, Maruyama R, Kusano M, Nishikawa N, Watanabe Y, Sasaki Y, Abe T, Yamamoto E, Tarasawa I, Sonoda T, Mori M, Imai K, Shinomura Y, Tokino T.

Cancer Sci. 2007 Jan;98(1):88-95.

23.

Therapeutic choice for craniofacial venous malformations.

Akita S, Akino K, Tanaka K, Anraku K, Yano H, Hirano A.

J Craniofac Surg. 2006 Jul;17(4):729-35.

PMID:
16877926
24.

Attenuation of cysteinyl leukotrienes induces human mesenchymal stem cell differentiation.

Akino K, Mineda T, Mori N, Hirano A, Imaizumi T, Akita S.

Wound Repair Regen. 2006 May-Jun;14(3):343-9.

PMID:
16808814
25.

The quality of pediatric burn scars is improved by early administration of basic fibroblast growth factor.

Akita S, Akino K, Imaizumi T, Tanaka K, Anraku K, Yano H, Hirano A.

J Burn Care Res. 2006 May-Jun;27(3):333-8.

PMID:
16679903
26.

Comparative genome analysis identifies the vitamin D receptor gene as a direct target of p53-mediated transcriptional activation.

Maruyama R, Aoki F, Toyota M, Sasaki Y, Akashi H, Mita H, Suzuki H, Akino K, Ohe-Toyota M, Maruyama Y, Tatsumi H, Imai K, Shinomura Y, Tokino T.

Cancer Res. 2006 May 1;66(9):4574-83.

27.

A polyurethane dressing is beneficial for split-thickness skin-graft donor wound healing.

Akita S, Akino K, Imaizumi T, Tanaka K, Anraku K, Yano H, Hirano A.

Burns. 2006 Jun;32(4):447-51. Epub 2006 Apr 18.

PMID:
16621321
28.

Elevated circulating leukemia inhibitory factor in patients with extensive burns.

Akita S, Akino K, Ren SG, Melmed S, Imaizumi T, Hirano A.

J Burn Care Res. 2006 Mar-Apr;27(2):221-5.

PMID:
16566572
29.

Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus.

Kusano M, Toyota M, Suzuki H, Akino K, Aoki F, Fujita M, Hosokawa M, Shinomura Y, Imai K, Tokino T.

Cancer. 2006 Apr 1;106(7):1467-79.

30.

Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines.

Terasawa K, Toyota M, Sagae S, Ogi K, Suzuki H, Sonoda T, Akino K, Maruyama R, Nishikawa N, Imai K, Shinomura Y, Saito T, Tokino T.

Br J Cancer. 2006 Mar 27;94(6):914-21.

31.

A basic fibroblast growth factor improved the quality of skin grafting in burn patients.

Akita S, Akino K, Imaizumi T, Hirano A.

Burns. 2005 Nov;31(7):855-8.

PMID:
16199295
32.

Small interfering RNA-induced CHFR silencing sensitizes oral squamous cell cancer cells to microtubule inhibitors.

Ogi K, Toyota M, Mita H, Satoh A, Kashima L, Sasaki Y, Suzuki H, Akino K, Nishikawa N, Noguchi M, Shinomura Y, Imai K, Hiratsuka H, Tokino T.

Cancer Biol Ther. 2005 Jul;4(7):773-80. Epub 2005 Jul 6.

PMID:
16123600
33.

Human mesenchymal stem cells successfully improve skin-substitute wound healing.

Nakagawa H, Akita S, Fukui M, Fujii T, Akino K.

Br J Dermatol. 2005 Jul;153(1):29-36.

PMID:
16029323
34.

The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer.

Akino K, Toyota M, Suzuki H, Mita H, Sasaki Y, Ohe-Toyota M, Issa JP, Hinoda Y, Imai K, Tokino T.

Gastroenterology. 2005 Jul;129(1):156-69.

PMID:
16012945
35.

Early cellular changes of human mesenchymal stem cells and their interaction with other cells.

Akino K, Mineda T, Akita S.

Wound Repair Regen. 2005 Jul-Aug;13(4):434-40.

PMID:
16008733
36.
37.

Upregulation of BNIP3 by 5-aza-2'-deoxycytidine sensitizes pancreatic cancer cells to hypoxia-mediated cell death.

Abe T, Toyota M, Suzuki H, Murai M, Akino K, Ueno M, Nojima M, Yawata A, Miyakawa H, Suga T, Ito H, Endo T, Tokino T, Hinoda Y, Imai K.

J Gastroenterol. 2005 May;40(5):504-10.

PMID:
15942716
38.

A novel molecular marker of pituitary tumor transforming gene involves in a rat liver regeneration.

Akino K, Akita S, Mizuguchi T, Takumi I, Yu R, Wang XY, Rozga J, Demetriou AA, Melmed S, Ohtsuru A, Yamashita S.

J Surg Res. 2005 Nov;129(1):142-6. Epub 2005 Jun 3.

PMID:
15936773
39.

Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours.

Murai M, Toyota M, Satoh A, Suzuki H, Akino K, Mita H, Sasaki Y, Ishida T, Shen L, Garcia-Manero G, Issa JP, Hinoda Y, Tokino T, Imai K.

Br J Cancer. 2005 Mar 28;92(6):1165-72.

40.

Aberrant methylation and silencing of the BNIP3 gene in colorectal and gastric cancer.

Murai M, Toyota M, Suzuki H, Satoh A, Sasaki Y, Akino K, Ueno M, Takahashi F, Kusano M, Mita H, Yanagihara K, Endo T, Hinoda Y, Tokino T, Imai K.

Clin Cancer Res. 2005 Feb 1;11(3):1021-7.

42.

Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.

Satoh A, Toyota M, Ikeda H, Morimoto Y, Akino K, Mita H, Suzuki H, Sasaki Y, Kanaseki T, Takamura Y, Soejima H, Urano T, Yanagihara K, Endo T, Hinoda Y, Fujita M, Hosokawa M, Sato N, Tokino T, Imai K.

Oncogene. 2004 Nov 25;23(55):8876-86.

PMID:
15467734
43.

Aberrant methylation and histone deacetylation associated with silencing of SLC5A8 in gastric cancer.

Ueno M, Toyota M, Akino K, Suzuki H, Kusano M, Satoh A, Mita H, Sasaki Y, Nojima M, Yanagihara K, Hinoda Y, Tokino T, Imai K.

Tumour Biol. 2004 May-Jun;25(3):134-40.

PMID:
15361710
44.
45.

Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer.

Obata T, Toyota M, Satoh A, Sasaki Y, Ogi K, Akino K, Suzuki H, Murai M, Kikuchi T, Mita H, Itoh F, Issa JP, Tokino T, Imai K.

Clin Cancer Res. 2003 Dec 15;9(17):6410-8.

46.

Bone morphogenetic protein-2 regulates proliferation of human mesenchymal stem cells.

Akino K, Mineta T, Fukui M, Fujii T, Akita S.

Wound Repair Regen. 2003 Sep-Oct;11(5):354-60.

PMID:
12950639
47.

Autocrine/paracrine involvement of parathyroid hormone-related peptide in vascular leiomyoma.

Naito S, Shimizu K, Akino K, Ohtsuru A, Watanabe M, Yamashita S, Sekine I.

Endocr J. 2002 Jun;49(3):335-41.

48.

Carcinoma of duodenum arising from Brunner's gland.

Akino K, Kondo Y, Ueno A, Yamazaki K, Hosokawa M, Shimoji H, Adachi T, Honda S, Ichiyanagi S, Akahonai Y, Fujisawa Y, Takahashi H, Arimura Y, Endo T, Imai K.

J Gastroenterol. 2002;37(4):293-6.

PMID:
11993514
49.

Leukemia inhibitory factor enhances bone formation in calvarial bone defect.

Dazai S, Akita S, Hirano A, Rashid MA, Naito S, Akino K, Fujii T.

J Craniofac Surg. 2000 Nov;11(6):513-20.

PMID:
11314490
50.

Parathyroid hormone-related peptide is a potent tumor angiogenic factor.

Akino K, Ohtsuru A, Kanda K, Yasuda A, Yamamoto T, Akino Y, Naito S, Kurokawa M, Iwahori N, Yamashita S.

Endocrinology. 2000 Nov;141(11):4313-6.

PMID:
11089567

Supplemental Content

Support Center